Key points The field of structural heart disease interventions is expanding rapidly. Advances in cardiac imaging are playing a central role in patient selection, imaging guidance, and follow-up of patients undergoing transcatheter mitral valve procedures (TCMVPs). Three-dimensional transesophageal echocardiography has…
Transcatheter therapies for both congenital and noncongenital structural heart lesions continue to expand in both their scope and complexity. The evolution of percutaneous treatment options for structural heart disease (SHD) has also come with advances in the imaging techniques associated…
Mitral stenosis (MS) is the most common form of rheumatic valve disease and produces significant disability, particularly in young and middle-aged adults. , Patients with severe MS usually develop fatigue, heart failure, atrial fibrillation, and thromboembolism. Of the many causes…